Remove 2010 Remove Nurses Remove Packaging
article thumbnail

Nurses and NHS staff protest over pay rise 'snub'

The Pharma Data

Hundreds of nurses and NHS staff in Wales are to protest at being excluded from a recent pay rise announcement. Ministers say they were working with unions to ensure the “best possible” pay package for all health workers. “I was so scared I even wrote a will,” said nurse Naomi Jenkins. Image copyright.

Nurses 52
article thumbnail

Deliberate Dysentery

Codon

With hepatitis C, what changed within the last 10 years was the development of direct-acting antivirals , or DAAs, which are packaged into pills that you can take once a day for a few months. A few people died in those early challenge trials, though, including a nurse named Clara Maass , who was challenged multiple times.

Vaccine 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CAPTIVATE Study Shows an IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Chemotherapy-Free Combination Has Potential to Provide Remission After Fixed-Duration Treatment for Chronic Lymphocytic Leukemia (CLL)

The Pharma Data

Advise nursing women to discontinue breastfeeding during treatment. 2010; 116(20): 4777–4787. 9 VENCLEXTA (venetoclax) [Package Insert].?North hepatic impairment, a dose reduction of at least 50% throughout treatment is recommended. . VENCLYXTO ® may cause embryo-fetal harm when administered to a pregnant woman. N Engl J Med.

article thumbnail

IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows Superior Progression-Free Survival Compared to Chlorambucil Plus Obinutuzumab in First-line Chronic Lymphocytic Leukemia (CLL) Phase 3 GLOW Study

The Pharma Data

Advise nursing women to discontinue breastfeeding during treatment. 2010; 116(20): 4777–4787. 8 VENCLEXTA (venetoclax) [Package Insert].?North?Chicago, For patients with severe (Child-Pugh C) hepatic impairment, a dose reduction of at least 50% throughout treatment is recommended. Accessed May 2021. 3 Shanafelt, et al.